Helios Klinikum Oberhausen
Helios Klinikum Oberhausen
Oberhausen, Germany1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients | Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, basal cell carcinoma, basal cell neoplasm, carcinoma, epithelial neoplasm, neoplasm, skin disorder, skin neoplasm | Recruiting | Phase 2 | 2026-03-11 | NCT06981325 |